Ragnar Linder

Insider profile

Currently holds positions in Pharmacolog I Uppsala AB (publ) and AlzeCure Pharma AB

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 21% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Pharmacolog I Uppsala AB (publ) April 29, 2019 -
Independent Director AlzeCure Pharma AB Jan. 1, 2017 -
Ragnar Linder's trades of AlzeCure Pharma AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
156.55
Quantity 52,769
Value SEK1,424,034
Transaction date
Purchase
Price
177.90
Quantity 97,557
Value SEK4,101,580
Transaction date
Purchase
Price
170.96
Quantity 65,274
Value SEK698,577
Transaction date
Purchase
Price
5.30
Quantity 4,434
Value SEK23,500
Transaction date
Purchase
Price
5.30
Quantity 10,566
Value SEK56,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-26 2022-12-23
B Purchase
52,769
156.55
SEK1,424,034 		52,769 156.55 SEK1,424,034
2021-08-31 2021-08-20
B Purchase
97,557
177.90
SEK4,101,580 		97,557 177.90 SEK4,101,580
2020-07-08 2020-07-08
B Purchase
65,274
170.96
SEK698,577 		65,274 170.96 SEK698,577
2020-05-28 2020-05-28
B Purchase
4,434
5.30
SEK23,500 		4,434 5.30 SEK23,500
2020-05-28 2020-05-27
B Purchase
10,566
5.30
SEK56,000 		10,566 5.30 SEK56,000